Examining Cytokines Levels in Individuals with Metabolic Syndrome and Non-metabolic Syndrome | Chapter 2 | Medical Science: Trends and Innovations Vol. 1

Background: Metabolic syndrome is characterized by abnormalities in blood pressure, blood sugar, waist circumference, and cholesterol or triglyceride levels. Cytokines, produced by immune system cells, act as messengers to regulate inflammation and immune response. Studies have demonstrated the contribution of cytokines to metabolic syndrome. Inflammatory cytokines such as Interleukin-6 (IL-6) and Tumor necrosis factor alpha (TNF-α) have been associated with metabolic syndrome and insulin resistance, a hallmark of the condition.

Aim: The unique aspect of this study is its primary focus on determining whether there is a distinction in inflammatory markers between individuals with metabolic syndrome and those without the condition.

Material and Methods: The study included 50 patients with metabolic syndrome and 50 healthy controls. The research was conducted at Indore Index Medical College & Research Centre. After obtaining approval, the study’s researchers commenced their work. Each subject provided informed consent prior to the study. Individuals with type 1 diabetes or clinical symptoms for fewer than five years and documented T2DM duration were excluded. Healthy controls (non-metabolic syndrome) were individuals without diabetes, multivitamin use, or comorbidities.

Statistical Analysis: Regressions were used to determine the relationship between two variables. Additionally, percentages were calculated. A significance level of p < 0.05 was considered significant.

Conclusion: The significance of these results cannot be overstated. The study’s findings unequivocally demonstrate that both pro-inflammatory and anti-inflammatory cytokines contribute to the development of secondary illnesses associated with metabolic syndrome. The study concluded that both pro-inflammatory and anti-inflammatory cytokines play a role in the development of secondary conditions associated with metabolic syndrome. Moreover, these analyzed cytokines may serve as biomarkers for early detection and diagnosis of secondary complications in individuals with metabolic syndrome.

 

Author (s) Details

 

Lingidi Jhansi Lakshmi
Department of Biochemistry, Hi-Tech Medical College & Hospital, Rourkela, India.

 

Doddigarla Zephy
Department of Biochemistry, Hi-Tech Medical College & Hospital, Rourkela, India.

 

Abdul Rab Alli
Department of Biochemistry, Hi-Tech Medical College & Hospital, Bhubaneswar, India.

Please see the book here:- https://doi.org/10.9734/bpi/msti/v1/3864

Assorted Advances Therapeutic Strategies of Inflammatory Arthritis | Chapter 13 | Research Trends and Challenges in Medical Science Vol. 7

 A type of inflammatory disease, arthritis is a complex group of conditions characterised by inflammation of the joints that can typically affect one or more joints, deformity, and disability. Various environmental and other causative factors affect approximately 100 different types of arthritis, but the two most common types are osteoarthritis and rheumatoid arthritis. Osteoarthritis can also have inflammatory effects, frequently carnaging the joint carti over time, whereas rheumatoid arthritis is an autoimmune condition that causes inflammatory joint symptoms in the body. Usage of biological agents targeting cytokines such as interleukin 1 (IL-1) alpha, beta, or tumour necrosis factor (TNF)-alpha in synovial rheumatoid fibroblasts that are potent metalloproteinase inductors (MMPs). They are engaged actively in mutual destruction. Different clinical and demographic characteristics of arthritis play a central role in the pathogenesis of inflammatory markers and have made it possible to develop highly efficient assorted treatment strategies of wide synthetic or traditional drug applicability, including NSAIDs. Corticosteroids, cytotoxic medicines, etc., but these medicines are associated with major side effects, whereas herbal medicines such as Curcuma longa, Boswellia, are effective for mild to moderate forms of inflammatory arthritis and contribute to improved performance.

Author(s) Details

Sudhanshu Mishra
School of Pharmaceutical Science, Rajiv Gandhi Proudyogiki Vishwavidyalay, Bhopal, India.

Disha Sharma
Dr M C Saxena College of Pharmacy, Lucknow, India.

Vikash Chaturvedi
LNCT University, Bhopal, India.

Sudhi Pandey
Swarrnim Startup & Innovation University, Gandhinagar, India.

Anshita Raghuvanshi
Dr M C Saxena College of Pharmacy, Lucknow, India.

View Book :- https://bp.bookpi.org/index.php/bpi/catalog/book/361